Verinovum, Inc. offers a Data Curation as a Service (DCaaS) platform designed to address the challenges of low-quality patient data in the healthcare industry. The company's proprietary combination of data curation and advanced enrichment processes, validated by clinical and database experts, promises to optimize data integrity across the care continuum. This, in turn, aims to enable stakeholders including payers, providers, and partners to make more informed and accurate decisions that improve patient outcomes while reducing unnecessary costs. Verinovum's approach involves focusing on the intricate parameters required to optimize clinical patient data within specific chronic and preventative care disease states. Their "data modules" are designed to enhance disease and care management programming, improve quality scoring, and advance payment model calculations. The process commences with a proprietary curation process to validate and cleanse data from disparate sources, followed by advanced enrichment methodologies incorporating standardization, normalization algorithms, and reference data sets. The company's technology has demonstrated significant results, such as a notable increase in the completeness of member data for a major payer organization, from 14% to 89%. Verinovum also offers consultations for those interested in learning more about their solutions. Founded in 2013, Verinovum operates in the intersection of Big Data and Healthcare industries, presenting an innovative solution for improving data quality within the healthcare sector. Despite the lack of specific investment information at the moment, Verinovum's DCaaS platform showcases potential for disruption and effectiveness in addressing the critical issue of healthcare data quality.
There is no investment information
No recent news or press coverage available for Verinovum, Inc..